Dear Ms Idiart,
I'm writing regarding Market Access field about paxlovlid. Could you please send us guidelines concerning clinical trials that we have to do to obtain the authorization ?
What are the recommendations for COVID treatment? Can you tell me how many people should be included in clinical trials ?
Please find attached the plan of clinical trials made by the company.
Best regards.
Claire Deroissart